NCT04457648View on ClinicalTrials.gov

Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Meibomian Gland Dysfunction
Interventions
DEVICE

manuka honey 16% eye drops ( Optimel )

16% manuka honey eye drops, australian FDA approved

DEVICE

systane eye drops

systane lubricant eye drops

Trial Locations (1)

Unknown

chinese university of Hong kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04457648 - Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease | Biotech Hunter | Biotech Hunter